For: | Han SX, Zhu Q, Ma JL, Zhao J, Huang C, Jia X, Zhang D. Lowered HGK expression inhibits cell invasion and adhesion in hepatocellular carcinoma cell line HepG2. World J Gastroenterol 2010; 16(36): 4541-4548 [PMID: 20857524 DOI: 10.3748/wjg.v16.i36.4541] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i36/4541.htm |
Number | Citing Articles |
1 |
Jungjae Lee, Seoyun Kim, Jihyeung Ju. Effects of White Sesame Seed Extract and β-Sitosterol on Growth, Migration, and Adhesion of H1299 Human Lung Cancer Cells. Journal of the Korean Society of Food Science and Nutrition 2015; 44(9): 1279 doi: 10.3746/jkfn.2015.44.9.1279
|
2 |
Koc-Kan Ho, K. Mark Parnell, Yi Yuan, Yong Xu, Steven G. Kultgen, Steven Hamblin, Thomas F. Hendrickson, Bai Luo, Jason M. Foulks, Michael V. McCullar, Steven B. Kanner. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors. Bioorganic & Medicinal Chemistry Letters 2013; 23(2): 569 doi: 10.1016/j.bmcl.2012.11.013
|
3 |
Zhenjie Bai, Qingmei Yao, Zhongyi Sun, Fang Xu, Jicheng Zhou. Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia. Technology in Cancer Research & Treatment 2019; 18: 153303381987392 doi: 10.1177/1533033819873927
|
4 |
Audrey Gallud, Ophélie Vaillant, Ludovic T. Maillard, Dominique P. Arama, Joëlle Dubois, Marie Maynadier, Vincent Lisowski, Marcel Garcia, Jean Martinez, Nicolas Masurier. Imidazopyridine-fused [1,3]-diazepinones: Synthesis and antiproliferative activity. European Journal of Medicinal Chemistry 2014; 75: 382 doi: 10.1016/j.ejmech.2014.01.044
|
5 |
Joseph V. Virbasius, Michael P. Czech. Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases. Trends in Endocrinology & Metabolism 2016; 27(7): 484 doi: 10.1016/j.tem.2016.04.006
|
6 |
Huai-Chia Chuang, Chih-Chi Chang, Chiao-Fang Teng, Chia-Hsin Hsueh, Li-Li Chiu, Pu-Ming Hsu, Ming-Ching Lee, Chung-Ping Hsu, Yi-Rong Chen, Yi-Chung Liu, Ping-Chiang Lyu, Tse-Hua Tan. MAP4K3/GLK Promotes Lung Cancer Metastasis by Phosphorylating and Activating IQGAP1. Cancer Research 2019; 79(19): 4978 doi: 10.1158/0008-5472.CAN-19-1402
|
7 |
Pieter H. Bos, Emily R. Lowry, Jonathon Costa, Sebastian Thams, Alejandro Garcia-Diaz, Arie Zask, Hynek Wichterle, Brent R. Stockwell. Development of MAP4 Kinase Inhibitors as Motor Neuron-Protecting Agents. Cell Chemical Biology 2019; 26(12): 1703 doi: 10.1016/j.chembiol.2019.10.005
|
8 |
Xuan Gao, Chenxi Gao, Guoxiang Liu, Jing Hu. MAP4K4: an emerging therapeutic target in cancer. Cell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0121-7
|
9 |
Darya A. Haas, Kiran Bala, Guntram Büsche, Magdalena Weidner-Glunde, Susann Santag, Semra Kati, Silvia Gramolelli, Modester Damas, Oliver Dittrich-Breiholz, Michael Kracht, Jessica Rückert, Zoltan Varga, György Keri, Thomas F. Schulz, Blossom Damania. The Inflammatory Kinase MAP4K4 Promotes Reactivation of Kaposi's Sarcoma Herpesvirus and Enhances the Invasiveness of Infected Endothelial Cells. PLoS Pathogens 2013; 9(11): e1003737 doi: 10.1371/journal.ppat.1003737
|
10 |
Sunil Kumar Singh, Ruchi Roy, Sandeep Kumar, Piush Srivastava, Saket Jha, Basabi Rana, Ajay Rana. Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases. Cancers 2023; 15(8): 2272 doi: 10.3390/cancers15082272
|
11 |
Mei-Hua Qiu, Yi-Ming Qian, Xiang-Li Zhao, Shou-Mei Wang, Xiao-Jun Feng, Xin-Fang Chen, Shu-Hui Zhang. Expression and prognostic significance of MAP4K4 in lung adenocarcinoma. Pathology - Research and Practice 2012; 208(9): 541 doi: 10.1016/j.prp.2012.06.001
|
12 |
Huai-Chia Chuang, Xiaohong Wang, Tse-Hua Tan. . Advances in Immunology 2016; 129: 277 doi: 10.1016/bs.ai.2015.09.006
|
13 |
O A Kent, K Fox-Talbot, M K Halushka. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Oncogene 2013; 32(20): 2576 doi: 10.1038/onc.2012.266
|
14 |
Sumit Kumar Anand, Mara Caputo, Ying Xia, Emma Andersson, Emmelie Cansby, Sima Kumari, Marcus Henricsson, Rando Porosk, Katharina Susanne Keuenhof, Johanna Louise Höög, Syam Nair, Hanns-Ulrich Marschall, Matthias Blüher, Margit Mahlapuu. Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage. Journal of Lipid Research 2022; 63(7): 100238 doi: 10.1016/j.jlr.2022.100238
|